HIGHLIGHTS
- who: Steven Simoens from the University of Catania, Italy have published the research work: Societal economic burden of multiple sclerosis and cost-effectiveness of disease-modifying therapies, in the Journal: (JOURNAL)
- what: The aim of this article is to provide a mini-review of the health economics of MS by focusing on the costs that MS imposes on society, by exploring the cost-effectiveness of DMTs, and by examining the methodology of economic evaluations of DMTs.
- how: The results indicated that the treatment sequence generating the highest health gain was not the same . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.